The NHS Obesity & Weight Management Formulary has been updated to align with new NICE guidance, including the addition of Semaglutide for reducing cardiovascular risk in overweight patients with CVD. The formulary is now split into separate oral and injectable pages for clearer prescribing, with improved consistency, added tick boxes, and updated advice on side effects, drug checks, and multivitamin use. Links and page navigation have been streamlined, making the template easier to use and more accurate for clinical teams.